DrugPatentWatch Database Preview
Patent: 10,081,657
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for Patent: 10,081,657
| Title: | Biosynthetic proline/alanine random coil polypeptides and their uses |
| Abstract: | The present invention relates to a biosynthetic random coil polypeptide or a biosynthetic random coil polypeptide segment or biosynthetic conjugate, in which the biosynthetic random coil polypeptide, the biosynthetic random coil polypeptide segment, or the biosynthetic conjugate comprises an amino acid sequence consisting solely of proline and alanine amino acid residues, wherein the amino acid sequence consists of at least about 50 proline (Pro) and alanine (Ala) amino acid residues. The at least about 50 proline (Pro) and alanine (Ala) amino acid residues may be (a) constituent(s) of a heterologous polypeptide or an heterologous polypeptide construct. Also uses and methods of use of these biosynthetic random coil polypeptides or polypeptide segments or conjugates are described. |
| Inventor(s): | Skerra; Arne (Freising, DE), Binder; Uli (Freising, DE), Schlapschy; Martin (Freising, DE) |
| Assignee: | TECHNISCHE UNIVERSITAT MUNCHEN (Munich, DE) XL-PROTEIN GMBH (Freising, DE) |
| Application Number: | 14/939,626 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,081,657
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biovitrum Ab | KINERET | anakinra | VIAL; SUBCUTANEOUS | 103950 | 003 | 2001-11-14 | Start Trial | TECHNISCHE UNIVERSITAT MUNCHEN (Munich, DE) XL-PROTEIN GMBH (Freising, DE) | 2030-05-21 | RX | search | |
| Biovitrum Ab | KINERET | anakinra | VIAL; SUBCUTANEOUS | 103950 | 002 | 2001-11-14 | Start Trial | TECHNISCHE UNIVERSITAT MUNCHEN (Munich, DE) XL-PROTEIN GMBH (Freising, DE) | 2030-05-21 | RX | search | |
| Biovitrum Ab | KINERET | anakinra | VIAL; SUBCUTANEOUS | 103950 | 001 | 2001-11-14 | Start Trial | TECHNISCHE UNIVERSITAT MUNCHEN (Munich, DE) XL-PROTEIN GMBH (Freising, DE) | 2030-05-21 | RX | search | |
| Ekr Therap | RETAVASE | reteplase | VIAL | 103786 | 001 | 1998-05-06 | Start Trial | TECHNISCHE UNIVERSITAT MUNCHEN (Munich, DE) XL-PROTEIN GMBH (Freising, DE) | 2030-05-21 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,081,657
| Country | Patent Number | Publication Date |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011144756 | Nov 24, 2011 |
| United States of America | 2013072420 | Mar 21, 2013 |
| United States of America | 2016137698 | May 19, 2016 |
| United States of America | 2018354992 | Dec 13, 2018 |
| United States of America | 9221882 | Dec 29, 2015 |
| Turkey | 201815734 | Nov 21, 2018 |
| Slovenia | 2571510 | Feb 28, 2019 |
| >Country | >Patent Number | >Publication Date |
